Sue Van is listed as a director on 1 SEC Form D filing by 1 issuer in Apr 2021: RxMP Therapeutics, Inc. (Miami, FL — biotechnology — 2021; $1.01M reported sold to 39 investors).
What this means One deal on file with the SEC, filed Apr 2021. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jy Wenche (1 shared filing) and Rifat Pamukcu (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Sue. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Sue Van and found 3 differences: Sue Van appears on 1 deal that stopped filing before reaching its target; Form D filed 21 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.